Paper Publications

• [1]  屈亚茹. The Crucial Role of SPP1 in Osteoporosis, Osteoarthritis, and Cancer.  Pharmaceutical Science Advances,  2025. 
• [2]  屈亚茹. TAMs-derived SPP1, regulated by HIF-1α/STAT3 signaling pathway, influences colorectal cancer malignant progression by activation of EMT via integrin αvβ3.  International Immunopharmacology,  159,  2025. 
• [3]  田慧芹. 基于Wnt/β-catenin信号通路的结直肠癌研究进展.  Chemistry of Life,  36,  71-80, 2016. 
• [4]  唐琳琳. 药理学教学方式研究.  食品与药品,  15,  453-455, 2013. 
• [5]  . Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/beta-catenin pathway in human colon cancer cells.  Biomedicine & Pharmacotherapy,  71,  46-52, 2015. 
• [6]  王星辰. Colorectal cancer cells establish metabolic reprogramming with cancer-associated fibroblasts (CAFs) through lactate shuttle to enhance invasion, migration, and angiogenesis.  Int Immunopharmacol,  2024. 
• [7]  姚红. The Cardioprotection of the Insulin-Mediated PI3K/Akt/mTOR Signaling Pathway.  American Journal of Cardiovascular Drugs,  14,  433-442, 2014. 
• [8]  周利春. The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy.  Journal of Molecular Endocrinology,  57,  R143-R152, 2016. 
• [9]  李水仙. The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment.  Biomedicine & Pharmacotherapy,  80,  127-135, 2016. 
• [10]  姚红. Protection of Luteolin-7-O-Glucoside Against Doxorubicin-Induced Injury Through PTEN/Akt and ERK Pathway in H9c2 Cells.  CARDIOVASCULAR TOXICOLOGY,  16,  101-110, 2016. 
• [11]  倪英倩. The roles of IDH1 in tumor metabolism and immunity.  Future Oncology,  18,  3941, 2022. 
• [12]  柳荷. The basic functions of phosphoglycerate kinase 1 and its roles in cancer and other diseases.  European Journal of Pharmacology,  920,  174835, 2022. 
• [13]  韩秀珍. 低分子量肝素对白细胞黏附和黏附分子表达的影响.  . 中国生化药物杂志,  24,  2003. 
• [14]  倪英倩. The roles of IDH1 in tumor metabolism and immunity.  Future Oncology,  18,  3941, 2023. 
• [15]  张宇. PP2A regulates metastasis and vasculogenic mimicry formation via PI3K/AKT/ZEB1 axis in non-small cell lung cancers..  J PHARMACOL SCI,  150,  56, 2022.